Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

US PTO grants new allowances to intellectual property covering Neurologix' GAD based delivery systems

Neurologix, Inc., a biotechnology company engaged in the development of innovative therapies for the brain and central nervous system, announced that the U.S. Patent and Trademark Office (US PTO) has expanded the intellectual property protections enabled by a previously issued patent that is central to Neurologix’s Parkinson’s disease program. The new allowances to U.S. Patent Number 765,446, entitled “Glutamic acid decarboxylase (GAD) based delivery systems,” broaden the patent’s coverage beyond Parkinson’s disease to include the use of GAD65 in the treatment of other neurological and related disorders.

27 Jan 2010

Researchers identify new drugs to protect brain cells from neurological disease

Researchers have identified a compound that mimics one of the brain's own growth factors and can protect brain cells against damage in several animal models of neurological disease.

27 Jan 2010

Scott & White conducts DBS research for Parkinson's patients

At Scott & White Memorial Hospital, a multi-disciplinary team of neurosurgeons, neurologists, neurophysiologist, neuropsychologists and a movement disorders specialist are offering hope to some Parkinson's patients with a treatment called Deep Brain Stimulation (DBS). DBS involves placing a thin wire that carries electrical currents deep within the brain on Parkinson's patients who are no longer benefitting from medications, and have significant uncontrollable body movements called dyskinesia. Scott & White is also performing research into the effects of DBS on the non-motor symptoms of Parkinson's disease including "drenching sweats," bladder dysfunction, depression, hallucination, anxiety, and dementia as well as intestinal disorders, loss of sense of smell, and sleep disturbances.

27 Jan 2010

AAN guideline finds diazepam drug is effective for treating children with cerebral palsy

A new guideline from the American Academy of Neurology and the Child Neurology Society finds botulinum toxin type A to be an effective treatment for spasticity, muscle tightness that interferes with movement, in children and adolescents with cerebral palsy, but poses some risk.

27 Jan 2010

Florida, California, Kansas eyeing cuts in Medicaid funding

The Daytona Beach News-Journal reports that as the recession continues to increase the number of people without jobs, many more are seeking health care through the state's Medicaid program, "driving up costs and playing a major role in a potential $3 billion state budget shortfall next year.

27 Jan 2010

NCMHD awards Weill Cornell Medical College $8M for establishing CEDREC in New York City

Weill Cornell Medical College has established a new research center to improve medical care in ethnically diverse and medically underserved communities in New York City.

23 Jan 2010

Study shows certain heart medications may decrease risk of Parkinson's disease

UCLA researchers have discovered that a specific type of medication used to treat cardiovascular conditions such as hypertension, angina and abnormal heart rhythms may also decrease the risk of developing Parkinson's disease.

22 Jan 2010

The American Journal of Pathology: Highlights from February 2010 issue

A group led by Dr. Peter Lloyd Jones at the University of Dundee, Dundee, Scotland; the University of Colorado Denver, Aurora, CO; and the University of Pennsylvania, Philadelphia, PA has demonstrated that tenascin-C affects proto-oncogene function in breast cancer. Their report can be found in the February 2010 issue of The American Journal of Pathology.

22 Jan 2010

Findings may aid in developing therapeutic drugs for stroke and other neurodegenerative diseases

Biomedical scientists from the University of Central Florida and Louisiana State University have identified a way to block a "cell death signal" that they believe triggers brain damage during strokes.

22 Jan 2010

Study lays groundwork to develop new treatments for cardiovascular disease and other conditions

In a significant step toward restoring healthy blood circulation to treat a variety of diseases, a team of scientists at Weill Cornell Medical College has developed a new technique and described a novel mechanism for turning human embryonic and pluripotent stem cells into plentiful, functional endothelial cells, which are critical to the formation of blood vessels.

21 Jan 2010

New computational model helps understand how dopamine medications affect non-motor functions

A new brain-based computational model is helping to understand how Parkinson's disease and dopamine medications-used to treat motor symptoms caused by the disease- can affect learning and attention.

21 Jan 2010

Research shows brain abnormalities develop years before Parkinson's symptoms appear

Scientists who have identified brain networks damaged in Parkinson's disease have new evidence that these systems become abnormal a few years before symptoms appear. And what's more, parts of the network appear to respond in a last ditch attempt to rescue the brain.

21 Jan 2010

Diamyd Medical executes share split

Diamyd Medical announces today that the company executes a 2:1 division of shares (i.e. a split), meaning that each share is divided into two shares of the same class.

20 Jan 2010

HSF1A stimulates more protein chaperones and reduces protein misfolding

Scientists at Duke University Medical Center have found some compounds that improve a cell's ability to properly "fold" proteins and could lead to promising drugs for degenerative nerve diseases, including Huntington's disease, Alzheimer's disease and Parkinson's disease.

20 Jan 2010

Preliminary data from Phase 1 study of Sangamo BioSciences' SB-728-T announced

Sangamo BioSciences, Inc. announced today that preliminary data from the University of Pennsylvania investigator sponsored Phase 1 safety study of Sangamo's zinc finger nuclease (ZFN) based product, SB-728-T, for HIV/AIDS were presented on Friday, January 15, 2010 at the Keystone Symposium Session "HIV Biology and Pathogenesis."

20 Jan 2010

Cognitive fluctuations more likely to occur in older persons with Alzheimer's disease

Cognitive fluctuations, or episodes when train of thought temporarily is lost, are more likely to occur in older persons who are developing Alzheimer's disease than in their healthy peers, according to scientists at Washington University School of Medicine in St. Louis.

19 Jan 2010

People with "mental lapses" more likely to have Alzheimer's disease

Older people who have "mental lapses," or times when their thinking seems disorganized or illogical or when they stare into space, may be more likely to have Alzheimer's disease than people who do not have these lapses, according to a study published in the January 19, 2010, print issue of Neurology-, the medical journal of the American Academy of Neurology.

19 Jan 2010

Neurosurgical journals influence neurosurgeons and their patients

A compendium of articles in the Journal of Neurosurgery (JNS) provides evidence that specialty medical journals are not only an invaluable resource to physicians and researchers, but to the media and public. Clinical and basic science papers do not have to be published in large, high-impact publications to garner attention, and in fact when it comes to specialized areas of medicine such as neurosurgery, publications devoted to the subspecialty produce many citation classics. "Citation classic" is a term given to articles that have been cited more than 400 times.

18 Jan 2010

Brain mechanisms behind compulsive behaviors in Parkinson's disease patients

New research unravels the brain mechanisms that underlie the ability of a standard drug treatment for Parkinson's to elicit compulsive behaviors in some patients with the disease. The study, published by Cell Press in the January 14th issue of the journal Neuron, provides fascinating new insight into the brain mechanisms that underlie a predisposition to behavioral addictions, such as pathological gambling and shopping.

18 Jan 2010

Dopamine replacement therapy causes brain dysfunction in patients with Parkinson disease, study says

People with Parkinson's Disease are more likely to display abnormal social behaviour and make poor decisions in ambiguous circumstances if they are pathological gamblers, according to research in the January issue of the European Journal of Neurology.

18 Jan 2010

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

US PTO grants new allowances to intellectual property covering Neurologix' GAD based delivery systems

Researchers identify new drugs to protect brain cells from neurological disease

Scott & White conducts DBS research for Parkinson's patients

AAN guideline finds diazepam drug is effective for treating children with cerebral palsy

Florida, California, Kansas eyeing cuts in Medicaid funding

NCMHD awards Weill Cornell Medical College $8M for establishing CEDREC in New York City

Study shows certain heart medications may decrease risk of Parkinson's disease

The American Journal of Pathology: Highlights from February 2010 issue

Findings may aid in developing therapeutic drugs for stroke and other neurodegenerative diseases

Study lays groundwork to develop new treatments for cardiovascular disease and other conditions

New computational model helps understand how dopamine medications affect non-motor functions

Research shows brain abnormalities develop years before Parkinson's symptoms appear

Diamyd Medical executes share split

HSF1A stimulates more protein chaperones and reduces protein misfolding

Preliminary data from Phase 1 study of Sangamo BioSciences' SB-728-T announced

Cognitive fluctuations more likely to occur in older persons with Alzheimer's disease

People with "mental lapses" more likely to have Alzheimer's disease

Neurosurgical journals influence neurosurgeons and their patients

Brain mechanisms behind compulsive behaviors in Parkinson's disease patients

Dopamine replacement therapy causes brain dysfunction in patients with Parkinson disease, study says

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Newsletters you may be interested in